The Deep Brain Stimulation (DBS) Devices Market is set to witness robust growth at a CAGR of 10.33% during the forecast period to be worth US$3.23 billion in 2030 from US$1.97 billion in 2025.
The global deep brain stimulation (DBS) devices market is poised for substantial growth, driven by the increasing prevalence of neurological disorders, technological advancements, and growing awareness of DBS therapy.
The global deep brain stimulation (DBS) devices market is poised for substantial growth, driven by the increasing prevalence of neurological disorders, technological advancements, and growing awareness of DBS therapy.
Market Trends
- Increasing Prevalence of Neurological Disorders: The rising incidence of neurological conditions such as Parkinson's disease, essential tremors, and dystonia is a primary driver of market growth. For instance, the Parkinson's Foundation estimates that over 10 million individuals worldwide suffer from Parkinson's disease. Stroke is another major factor; globally, one in every four people aged 25 or older is expected to experience a stroke in their lifetime.
- Technological Advancements: Ongoing technological advancements, including improvements in lead design, implantable pulse generators, remote monitoring capabilities, and increased computing power, are enhancing the effectiveness and safety of DBS therapy. Recent innovations include smaller, rechargeable DBS systems with remote programming capabilities.
- Growing Awareness and Acceptance: Increasing global awareness and acceptance of DBS therapy, facilitated by governmental initiatives and policies, are contributing to market expansion.
- Minimally Invasive Procedures: Escalating demand for minimally invasive procedures is also propelling the market growth. A novel miniaturized DBS device, the Picostim DBS system, aims to mitigate complications and reduce costs associated with traditional DBS surgery.
Geographical Outlook
- North America: North America is expected to dominate the DBS devices market due to increasing technological advancements, a strong research and development ecosystem, and the established presence of major market players in the U.S.
- Europe: Europe is projected to experience significant growth due to advancements in its healthcare sector and a focus on minimally invasive medical interventions. Increasing government spending on mental health services is also a driving factor in the UK.
- Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth, driven by increasing disposable incomes, growing awareness of neurological conditions, and government support for healthcare initiatives.
- South America and MEA: South America and the Middle East & Africa are expected to experience slower growth due to a lower rate of technological advancements in their healthcare sectors.
Reasons for buying this report::
- Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
- Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
- Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
- Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
- Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What can businesses use this report for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence.Report Coverage:
- Historical data & forecasts from 2022 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
The Deep Brain Stimulation Devices Market is analyzed into the following segments:
By Application
- Parkinson's Disease
- Epilepsy
- Essential Tremor
- Dystonia
- Others (OCD and Tourette syndrome)
By Product Type
- Single-channel Deep Brain Stimulators
- Dual-channel Deep Brain Stimulators
By End-User
- Hospitals
- Ambulatory Surgical Centers
- Neurological Clinics
By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Spain
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Indonesia
- Others
- South America
- Brazil
- Argentina
- Others
- Middle East & Africa
- Saudi Arabia
- UAE
- Others
Table of Contents
1. EXECUTIVE SUMMARY1.1. Market Overview
1.2. Key Trends and Insights
1.3. Market Size and Forecast
2. INTRODUCTION
2.1. Definition and Scope
2.2. Growing urbanization
2.3. Importance of sustainability
3. MARKET DYNAMICS
3.1. Drivers of Market Growth
3.2. Challenges and Barriers
3.3. Opportunities in Emerging Markets
3.4. Regulatory and Environmental Factors
4. SEGMENTATION ANALYSIS
4.1. By Application
4.1.1. Parkinson's Disease
4.1.2. Epilepsy
4.1.3. Essential Tremor
4.1.4. Dystonia
4.1.5. Others
4.2. By Product Type
4.2.1. Single-channel Deep Brain Stimulators
4.2.2. Dual-channel Deep Brain Stimulators
4.3. By End-User
4.3.1. Hospitals
4.3.2. Ambulatory Surgical Centers
4.3.3. Neurological Clinics
4.4. By Geography
4.4.1. North America
4.4.1.1. United States
4.4.1.2. Canada
4.4.1.3. Mexico
4.4.2. Europe
4.4.2.1. United Kingdom
4.4.2.2. Germany
4.4.2.3. France
4.4.2.4. Spain
4.4.2.5. Others
4.4.3. Asia Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.3.4. South Korea
4.4.3.5. Australia
4.4.3.6. Singapore
4.4.3.7. Indonesia
4.4.3.8. Others
4.4.4. South America
4.4.4.1. Brazil
4.4.4.2. Argentina
4.4.4.3. Others
4.4.5. Middle East & Africa
4.4.5.1. Saudi Arabia
4.4.5.2. UAE
4.4.5.3. Others
5. COMPETITIVE LANDSCAPE
5.1. Key Market Players
5.2. Company Profiles and Strategies
5.3. Market Share Analysis
6. MARKET TRENDS AND INNOVATIONS
6.1. Growing prevalence of neurological disorders.
6.2. Increasing technological advancement.
6.3. Innovations and investments in healthcare technology.
6.4. Growing global acceptance and awareness of deep brain stimulation.
7. MARKET OUTLOOK AND FORECAST
7.1. Market Size and Growth Projections (2023-2030)
7.2. Regional Market Outlook
8. REGULATORY FRAMEWORK
8.1. Intellectual Property Rights
8.2. Data Privacy and Security
9. CASE STUDIES AND INDUSTRY APPLICATIONS
9.1. Parkinson’s and Epilepsy devices
9.2. Single and Dual-channel Deep Brain Stimulators
9.3. Equipment and Devices for neurological application
10. CONCLUSION AND RECOMMENDATIONS
10.1. Key Takeaways
10.2. Strategic Recommendations for Stakeholders
11. APPENDICES
11.1. Research Methodology
11.2. Data Sources and References
11.3. Glossary of Terms
Companies Mentioned
- Boston Scientific Corporation
- Abbott
- Medtronic plc
- Renishaw plc
- NeuroPace Inc
- Beijing Pinchi Medical Equipment Co., Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 148 |
| Published | January 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 1.97 Billion |
| Forecasted Market Value ( USD | $ 3.23 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |
